Ardent Health (NYSE:ARDT) Now Covered by UBS Group

Key Points

• UBS Group initiated coverage of Ardent Health (NYSE: ARDT) with a "buy" rating and set a price target of $17.00, indicating a potential upside of 25.93% from the current price.
• Other analysts have mixed ratings, with Royal Bank of Canada setting a $21.00 price target while Bank of America downgraded their rating to "underperform" with a reduced target of $14.60.
• Ardent Health recently reported earnings of $0.52 EPS, surpassing estimates, and announced it expects to post 1.23 EPS for the current fiscal year.

Stock analysts at UBS Group began coverage on shares of Ardent Health (NYSE:ARDT - Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. The firm set a "buy" rating and a $17.00 price target on the stock. UBS Group's price target would suggest a potential upside of 31.99% from the stock's previous close.

A number of other equities analysts have also recently weighed in on ARDT. Stephens reissued an "overweight" rating and issued a $21.00 price target on shares of Ardent Health in a research note on Tuesday, May 20th. Bank of America cut Ardent Health from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $15.50 to $14.60 in a research note on Wednesday, July 16th. Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 9th. KeyCorp lowered their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Finally, JPMorgan Chase & Co. lowered their target price on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a research note on Monday, August 11th. Nine analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $19.33.

Ardent Health Trading Down 1.5%

ARDT traded down $0.20 during trading on Wednesday, reaching $12.88. The company had a trading volume of 87,727 shares, compared to its average volume of 391,234. The firm's 50-day simple moving average is $12.31 and its 200 day simple moving average is $13.12. The company has a market cap of $1.84 billion, a price-to-earnings ratio of 7.12, a PEG ratio of 5.78 and a beta of 0.29. Ardent Health has a 12-month low of $10.10 and a 12-month high of $20.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. The firm had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Equities research analysts anticipate that Ardent Health will post 1.23 earnings per share for the current year.

Institutional Trading of Ardent Health

A number of large investors have recently bought and sold shares of ARDT. Vanguard Group Inc. grew its position in Ardent Health by 368.9% in the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock valued at $18,296,000 after acquiring an additional 1,046,845 shares during the period. Goldman Sachs Group Inc. boosted its stake in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Ardent Health by 75.6% in the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company's stock worth $22,332,000 after purchasing an additional 703,739 shares in the last quarter. SageView Advisory Group LLC boosted its stake in Ardent Health by 367.2% in the second quarter. SageView Advisory Group LLC now owns 790,663 shares of the company's stock worth $10,800,000 after purchasing an additional 621,430 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Ardent Health in the first quarter worth $6,010,000.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.